Helix 8 of leukotriene B4 type-2 receptor is required for the folding to pass the quality control in the endoplasmic reticulum

FASEB Journal

Volumn 23, Issue 5, 2009, Pages 1470-1481

  Yasuda, Daisuke ^a   Okuno, Toshiaki ^b   Yokomizo, Takehiko ^b   Hori, Tetsuya ^c   Hirota, Nobuaki ^a   Hashidate, Tomomi ^a   Miyano, Masashi ^c   Shimizu, Takao ^a   Nakamura, Motonao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c RIKEN HARIMA INSTITUTE   (Japan)

Author keywords

12 HHT; ERAD; G protein coupled receptor; Pharmacological chaperone; Trafficking

Indexed keywords

AMINO ACID; CALCIUM ION; DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR TYPE 2; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR TYPE 2; UNCLASSIFIED DRUG;

ALPHA HELIX; ALPHA HELIX 8; ARTICLE; CELL SURFACE; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN FOLDING; QUALITY CONTROL;

AMINO ACID SEQUENCE; CALCIUM; CALCIUM SIGNALING; ENDOPLASMIC RETICULUM; FATTY ACIDS, UNSATURATED; HELA CELLS; HUMANS; PROTEIN FOLDING; PROTEIN TRANSPORT; RECEPTORS, DOPAMINE D1; RECEPTORS, LEUKOTRIENE B4; RECEPTORS, LYSOPHOSPHATIDIC ACID;

EID: 70349312467     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-125385     Document Type: Article

References (52)

1. Lagerstrom, M. C., and Schioth, H. B. (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339-357
2. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. (2000) Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745 (Pubitemid 30650186)
3. Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G., Thian, F. S., Kobilka, T. S., Choi, H. J., Kuhn, P., Weis, W. I., Kobilka, B. K., and Stevens, R. C. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258-1265 (Pubitemid 350172884)
4. Murakami, M., and Kouyama, T. (2008) Crystal structure of squid rhodopsin. Nature 453, 363-367
5. Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G., Tate, C. G., and Schertler, G. F. (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454, 486-491
6. Jaakola, V. P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y., Lane, J. R., Ijzerman, A. P., and Stevens, R. C. (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 21, 1211-1217
7. Okuno, T., Ago, H., Terawaki, K., Miyano, M., Shimizu, T., and Yokomizo, T. (2003) Helix 8 of the leukotriene B4 receptor is required for the conformational change to the low affinity state after G-protein activation. J. Biol. Chem. 278, 41500-41509 (Pubitemid 37280979)
8. Fritze, O., Filipek, S., Kuksa, V., Palczewski, K., Hofmann, K. P., and Ernst, O. P. (2003) Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc. Natl. Acad. Sci. U. S. A. 100, 2290-2295 (Pubitemid 36297492)
9. Anavi-Goffer, S., Fleischer, D., Hurst, D. P., Lynch, D. L., Barnett-Norris, J., Shi, S., Lewis, D. L., Mukhopadhyay, S., Howlett, A. C., Reggio, P. H., and Abood, M. E. (2007) Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms. J. Biol. Chem. 282, 25100-25113 (Pubitemid 47347562)
10. Delos Santos, N. M., Gardner, L. A., White, S. W., and Bahouth, S. W. (2006) Characterization of the residues in helix 8 of the human beta1-adrenergic receptor that are involved in coupling the receptor to G proteins. J. Biol. Chem. 281, 12896-12907
11. Sano, T., Ohyama, K., Yamano, Y., Nakagomi, Y., Nakazawa, S., Kikyo, M., Shirai, H., Blank, J. S., Exton, J. H., and Inagami, T. (1997) A domain for G protein coupling in carboxyl-terminal tail of rat angiotensin II receptor type 1A. J. Biol. Chem. 272, 23631-23636 (Pubitemid 27410935)
12. Kang, D. S., and Leeb-Lundberg, L. M. (2002) Negative and positive regulatory epitopes in the C-terminal domains of the human B1 and B2 bradykinin receptor subtypes determine receptor coupling efficacy to G(q/11)-mediated [correction of G(9/11)-mediated] phospholipase Cbeta activity. Mol. Pharmacol. 62, 281-288 (Pubitemid 34804107)
13. Zhong, M., Navratil, A. M., Clay, C., and Sanborn, B. M. (2004) Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function. Biochemistry 43, 3490-3498 (Pubitemid 38391704)
14. Tai, A. W., Chuang, J. Z., Bode, C., Wolfrum, U., and Sung, C. H. (1999) Rhodopsin's carboxy-terminal cytoplasmic tail acts as a membrane receptor for cytoplasmic dynein by binding to the dynein light chain Tctex-1. Cell 97, 877-887 (Pubitemid 29375047)
15. Bermak, J. C., Li, M., Bullock, C., and Zhou, Q. Y. (2001) Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3, 492-498 (Pubitemid 32422085)
16. Schulein, R., Hermosilla, R., Oksche, A., Dehe, M., Wiesner, B., Krause, G., and Rosenthal, W. (1998) A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS. M6 cells. Mol. Pharmacol. 54, 525-535 (Pubitemid 28442945)
17. Robert, J., Clauser, E., Petit, P. X., and Ventura, M. A. (2005) A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membrane. J. Biol. Chem. 280, 2300-2308
18. VanLeeuwen, D., Steffey, M. E., Donahue, C., Ho, G., and MacKenzie, R. G. (2003) Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal diisoleucine sequence at codons 316/317. J. Biol. Chem. 278, 15935-15940 (Pubitemid 36799711)
19. Duvernay, M. T., Zhou, F., and Wu, G. (2004) A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J. Biol. Chem. 279, 30741-30750 (Pubitemid 38938007)
20. Shimizu, T., and Wolfe, L. S. (1990) Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 1-15 (Pubitemid 20187797)
21. Serhan, C. N., Haeggstrom, J. Z., and Leslie, C. C. (1996) Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J. 10, 1147-1158
22. Shimizu, T. (2009) Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49, 123-150
23. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., and Shimizu, T. (1997) A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620-624 (Pubitemid 27248768)
24. Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., and Shimizu, T. (2000) A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192, 421-432 (Pubitemid 30629167)
25. Okuno, T., Iizuka, Y., Okazaki, H., Yokomizo, T., Taguchi, R., and Shimizu, T. (2008) 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2. J. Exp. Med. 205, 759-766 (Pubitemid 351549875)
26. Bernier, V., Lagace, M., Bichet, D. G., and Bouvier, M. (2004) Pharmacological chaperones: potential treatment for conformational diseases. Trends Endocrinol. Metab. 15, 222-228 (Pubitemid 38833993)
27. Conn, P. M., Ulloa-Aguirre, A., Ito, J., and Janovick, J. A. (2007) G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol. Rev. 59, 225-250 (Pubitemid 47481435)
28. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (Pubitemid 19125653)
29. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
30. Tan, C. M., Nickols, H. H., and Limbird, L. E. (2003) Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation. J. Biol. Chem. 278, 35678-35686
31. Rutz, C., Renner, A., Alken, M., Schulz, K., Beyermann, M., Wiesner, B., Rosenthal, W., and Schulein, R. (2006) The corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide. J. Biol. Chem. 281, 24910-24921 (Pubitemid 44274262)
32. Janicki, S., and Monteiro, M. J. (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). J. Cell Biol. 139, 485-495 (Pubitemid 27459319)
33. Ghosh, M., Loper, R., Gelb, M. H., and Leslie, C. C. (2006) Identification of the expressed form of human cytosolic phospholipase A2beta (cPLA2beta): cPLA2beta3 is a novel variant localized to mitochondria and early endosomes. J. Biol. Chem. 281, 16615-16624
34. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 (Pt 2), 110-119
35. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (Pubitemid 28443603)
36. R. A. Laskowski, M. W. M. D. S. Moss, and J. M. Thornton (1993) PROCHECK - a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283-291
37. Ishii, S., Kihara, Y., and Shimizu, T. (2005) Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 280, 9083-9087 (Pubitemid 40409602)
38. Iizuka, Y., Yokomizo, T., Terawaki, K., Komine, M., Tamaki, K., and Shimizu, T. (2005) Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes. J. Biol. Chem. 280, 24816-24823 (Pubitemid 40934572)
39. Yokomizo, T., Kato, K., Hagiya, H., Izumi, T., and Shimizu, T. (2001) Hydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2. J. Biol. Chem. 276, 12454-12459 (Pubitemid 37385420)
40. Okuno, T., Yokomizo, T., Hori, T., Miyano, M., and Shimizu, T. (2005) Leukotriene B4 receptor and the function of its helix 8. J. Biol. Chem. 280, 32049-32052 (Pubitemid 41361808)
41. Noorwez, S. M., Kuksa, V., Imanishi, Y., Zhu, L., Filipek, S., Palczewski, K., and Kaushal, S. (2003) Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa. J. Biol. Chem. 278, 14442-14450 (Pubitemid 36799997)
42. Janovick, J. A., Maya-Nunez, G., and Conn, P. M. (2002) Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J. Clin. Endocrinol. Metab. 87, 3255-3262 (Pubitemid 34816374)
43. Fan, J., Perry, S. J., Gao, Y., Schwarz, D. A., and Maki, R. A. (2005) A point mutation in the human melanin concentrating hormone receptor 1 reveals an important domain for cellular trafficking. Mol. Endocrinol. 19, 2579-2590 (Pubitemid 41362670)
44. Petaja-Repo, U. E., Hogue, M., Bhalla, S., Laperriere, A., Morello, J. P., and Bouvier, M. (2002) Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J. 21, 1628-1637 (Pubitemid 34614619)
45. Robert, J., Auzan, C., Ventura, M. A., and Clauser, E. (2005) Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone. J. Biol. Chem. 280, 42198-42206 (Pubitemid 43023190)
46. Morello, J. P., Salahpour, A., Laperriere, A., Bernier, V., Arthus, M. F., Lonergan, M., Petaja-Repo, U., Angers, S., Morin, D., Bichet, D. G., and Bouvier, M. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105, 887-895 (Pubitemid 30203061)
47. Hinney, A., Schmidt, A., Nottebom, K., Heibult, O., Becker, I., Ziegler, A., Gerber, G., Sina, M., Gorg, T., Mayer, H., Siegfried, W., Fichter, M., Remschmidt, H., and Hebebrand, J. (1999) Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 84, 1483-1486 (Pubitemid 30644420)
48. Whistler, J. L., Enquist, J., Marley, A., Fong, J., Gladher, F., Tsuruda, P., Murray, S. R., and Von Zastrow, M. (2002) Modulation of postendocytic sorting of G protein-coupled receptors. Science 297, 615-620 (Pubitemid 34815348)
49. Simonin, F., Karcher, P., Boeuf, J. J., Matifas, A., and Kieffer, B. L. (2004) Identification of a novel family of G protein-coupled receptor associated sorting proteins. J. Neurochem. 89, 766-775 (Pubitemid 38534161)
50. McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., and Foord, S. M. (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393, 333-339 (Pubitemid 28269699)
51. Fitzsimmons, T. J., Zhao, X., and Wank, S. A. (2003) The extracellular domain of receptor activity-modifying protein 1 is sufficient for calcitonin receptor-like receptor function. J. Biol. Chem. 278, 14313-14320 (Pubitemid 36799981)
52. Udawela, M., Hay, D. L., and Sexton, P. M. (2004) The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin. Cell. Dev. Biol. 15, 299-308 (Pubitemid 38581998)